Archive
Browse market commentary, macro analysis, and student-led reporting.
MarketsGlobal Healthcare19 Jun 2026
Novo Nordisk and Eli Lilly have proven GLP-1 drugs can deliver surgery-level weight loss - but with patients regaining much of it after stopping, the market's real value may depend on long-term adherence rather than who wins on efficacy.
GLP-1ObesityNovo NordiskEli LillyPharmaceuticals
Abdul Wasey Bhatti5 min read
Read ArticleThoma Bravo's $5bn Medallia loss and EQT's £10.7bn Intertek acquisition tell the same story from opposite ends. Private equity's software bet has failed. The platform strategy is what comes next.
Private EquitySoftwareMergers and AcquisitionsEQTThoma Bravo
Alexander Eklund8 min read
Read ArticleMarkets19 Jun 2026
Boots looked like a deal story, but choosing a $10bn sale over a London float is really a verdict on the IPO: when a listing can't promise a price or a date, certainty wins.
Private EquityIPOsBootsLondon Stock Exchange
Abir Ghosh Biswas6 min read
Read ArticleMarkets17 Jun 2026
The proposed takeover highlights how ownership of digital platforms is becoming just as important as ownership of the content itself.
Fox CorporationRokuStreamingMergers and AcquisitionsConnected TV
Gaurav Bohra7 min read
Read ArticleA federal court ruled Google's search dominance is illegal. The remedies are an attempt to dismantle a monopoly built on data, defaults, and self-reinforcing scale. Whether they can work is an open question.
GoogleAntitrustMonopolyNetwork EffectsCompetition
Jay Patel9 min read
Read ArticleThe new chairman of the world's most powerful central bank faces a problem his predecessor spent eight years navigating and never quite solved: inflation that won't obey. Only this time, the White House isn't demanding he fix it, it's cheering it on.
Federal ReserveInflationMonetary PolicyBank of EnglandUnited States
Raghu Kohli7 min read
Read ArticleMicroMarketsOpinion15 Jun 2026
Active investors are clamouring for a piece of the biggest IPO to date, and passive investors don't have a choice but to take a slice. But what is everyone actually buying?
Martim Domingos7 min read
Read ArticleMarketsPrivate Equity12 Jun 2026
Apollo's co-president warned of a private equity reckoning at SuperReturn in Berlin, then withdrew a £1.5bn bid for Bodycote two days later. The contradiction tells you everything about where the industry stands.
Private EquityApolloUnited KingdomMergers and AcquisitionsSpaceX
Alexander Eklund6 min read
Read ArticlePrivate EquityGlobal Healthcare12 Jun 2026
As AI clouds software valuations, private equity is pivoting towards healthcare – a sector whose demand is underpinned by demographics and disease burden that can be forecasted decades ahead.
Private EquityHealthcareMergers and AcquisitionsDemographicsGlobal Healthcare
Abdul Wasey Bhatti6 min read
Read ArticleMarketsPrivate Equity4 Jun 2026
As Bain and GHO rotate into Japan and healthcare, Astorg cannot raise a fund and JPMorgan quietly offloads NAV loan exposure. The private equity industry is not in a slowdown. It is in a shake-out.
Private EquityJapanHealthcareMergers and AcquisitionsArtificial Intelligence
Alexander Eklund8 min read
Read ArticleThe value of a degree is under siege as generative AI threatens to turn academic achievement into a hollow commodity.
Martim Domingos15 min read
Read ArticleAs AI disruption freezes software heavy buyout funds and retail capital retreats, a handful of firms are moving decisively in the opposite direction. The private equity market is splitting into winners and losers in real time.
Private EquityArtificial IntelligenceMergers and AcquisitionsSoftwareIran
Alexander Eklund8 min read
Read Article